The massive PBM’s announcement comes as the drug middlemen attempt to lessen regulatory scrutiny. The company also said it will move to a cost-plus reimbursement model for in-network pharmacies.
Cigna’s Express Scripts to transition away from rebate drug model Read More »
La tecnología láser ha revolucionado la forma en que vivimos, producimos y creamos. Desde los procesos industriales hasta el arte, la medicina y la educación, el láser se ha convertido en una herramienta esencial del mundo contemporáneo. Su precisió …
Measuring financial returns from AI can be challenging, experts said at the HLTH conference last week. But other metrics, like provider and patient satisfaction, are important too — and also impact providers’ bottom lines.
Health systems are racing to adopt AI. But can they prove its value? Read More »
The for-profit operator’s guidance raise is “cautious,” one analyst said. Still, HCA is staring down challenges like the potential expiration of more generous Affordable Care Act subsidies.
HCA raises 2025 guidance, but eyes looming headwinds Read More »
Plans found 39% of claims submitted to independent dispute resolution last year were actually ineligible for the process, but arbiters themselves caught only 17% of improper cases, according to AHIP and the BCBSA.
High volume of surprise billing disputes are ineligible for arbitration, insurers allege Read More »
En un ecosistema informativo saturado, distinguir entre evidencia y espectáculo se ha convertido en un desafío cotidiano. La divulgación científica no sólo consiste en contar hallazgos; también es enseñar a pensar con números: compren …
New interim data from a Phase III trial puts the company on track to file for FDA approval next year in an indication that not only lacks a disease-modifying treatment but suffered significant setbacks after a patient died in a clinical trial for Sarepta’s investigational gene therapy.
BridgeBio Pops on Late-Stage Limb-Girdle Muscular Dystrophy Data Read More »
Mayo Clinic and QAS.AI will receive funding and mentorship to help advance their projects.
Learning and development has proven key to fighting burnout and ensuring the success of the health system’s people managers, Deborah Yount told HR Dive.
Intellia earlier this year reported a similar grade 4 liver enzyme elevation associated with the gene therapy nexiguran ziclumeran, though analysts at BMO Capital Markets at the time brushed it off as a “non-concern.”
